March 14, 2019
BioTime Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
Completed Acquisition of Asterias Biotherapeutics, Inc.
Completed Distribution of AgeX Therapeutics Shares to BioTime
Shareholders
Entered Into Exclusive Collaboration with Orbit Biom…